PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS,RHEUMATOID ARTHRITIS,TREMORS/PARKINSON'S DISEASE,MULTIPLE SCLEROSIS,NON-VIRAL BASED CANCERS,ALZHEIMER'S DISEASE,MUSCULAR DYSTROPHY,ATTENTION DEFICIT DISORDER,ATTENTION DEFICIT HYPERACTIVITY DISORDER,COMPLEX REGIONAL PAIN SYNDROME,DIABETES,NEUROPATHIC PAIN,SPIDER ARTHRITIS,WEST NILE VIRUS,FIBROMYALGIA,SHINGLES,GOUT,MIGRAINE HEADACHES,SENILE DEMENTIA,POST POLIO SYNDROME,CENTRAL VIRUS DEAFNESS,ASTHMA,CHRONIC PAIN OF UNKNOWN ORIGIN AND HEPATITIS C
The present invention provides a composition and method for treating diseases associated with demyelination of the nerves, such as ALS, RA, Tremors/Parkinson's Disease, and MS, Alzheimer's disease, ALS, Guillain-Barre syndrome, atherosclerosis, schizophrenia, Tremors/Parkinsons' s disease, senile dementia, Muscular Dystrophy, Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, Complex Regional Pain Syndrome, Diabetes, Neuropathic Pain, Spider Arthritis West Nile Virus,, Fibromyalgia, Shingles, Gout, Migraine Headaches, Post Polio Syndrome, Central Virus Deafness, Asthma, Chronic Pain Of Unknown Origin and Hepatitis C and for treating non-viral based cancers. By administering measured doses of an immunity-provoking agent and a bacterial antigen activator, patients suffering from ALS, RA, MS, Tremors/Parkinson's Disease, and prostate cancer and others realized immediate beneficial results with no side effects.
